The promise is seductive: boost your body's own GLP-1 naturally, skip the medication, get the results
What we do have is a narrow slice of human data from one proof-of-concept clinical trial [3] , early-phase pharmacokinetic work in healthy volunteers [2] , and a set of theoretical concerns from ipamorelin's mechanism that have not been observed in humans but follow logically from what the compound does
In line, TGR5 and FXR agonists have shown promising results in the treatment of metabolic and inflammatory diseases, such as IBD and T2D ( Conclusion and Perspective Exploring the role of EEC and incretin hormones beyond blood glucose control is still in its infancy
The FDA's published novel drug approval lists for 2024, 2025, and 2026 do not include tesofensine
People exploring this peptide often talk about its potential role in: Supporting recovery Enhancing muscle-building programs Assisting body-composition routines Smooth, steady GH stimulation Its also one of the most popular peptides to stack with CJC-1295